The Power Play by The Market Herald Releases a New Interview with Algernon Pharmaceuticals Discussing Their Latest News tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said it has set up Algernon NeuroScience (AGN Neuro), a new wholly-owned private subsidiary of AGN.
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Ifenprodil.
VANCOUVER, British Columbia, Oct. 24, 2022 Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has entered an. | October 24, 2022